SIXPEX Semaglutide 5mg

Ozempic / Wegovy

Pack	5mg vial

Brand	Sixpex Labs

✓ Significant Weight Loss – Average 12-15% body weight reduction in clinical trials
✓ Powerful Appetite Suppression – Eliminates hunger and food cravings
✓ Proven Track Record – Over 15 years of clinical use and research
✓ Improves Metabolic Health – Lowers blood sugar, improves insulin sensitivity

$79.90

In stock

For Beginners

For Beginners	Yes

Popularity

Rating	★★★★★

Strength Gain

Strength Gains	☆☆☆☆☆

Mass Gain

Mass Gain	☆☆☆☆☆

For Women

For Women	Yes

Side Effects

Side Effects Profile	★★☆☆☆

Fat Loss

Weight Loss	★★★★★

Use Form

Intake	Subq

Why You Should Buy SIXPEX Semaglutide 5mg at Steroiduck?

At Steroiduck, we are committed to offering you the best quality anabolic steroids, peptides, HGH and SARMs You can count on. Every product goes through rigorous testing in a laboratory because we believe that quality cannot be sacrificed. Our reputation is built on providing honest, discreet USA domestic shipping and trustworthy secure payment methods to keep your information safe. When you buy SIXPEX Semaglutide 5mg with us, you’re not just getting some supplement – you’re getting a promise of ultimate satisfaction based on years of commitment to quality.

What It Does

Semaglutide 5mg contains Semaglutide at 5 milligrams per vial – a powerful GLP-1 receptor agonist that’s revolutionized weight loss medicine. Originally developed for Type 2 diabetes (sold as Ozempic) and later approved for weight loss (sold as Wegovy), Semaglutide produces significant, sustained fat loss through appetite regulation and metabolic enhancement.

When you inject Semaglutide, it mimics GLP-1, a natural hormone that regulates appetite, blood sugar, and digestion. This creates dramatic appetite suppression, reduced food cravings, delayed gastric emptying (staying full longer), and improved insulin sensitivity. Unlike stimulants or harsh diet drugs, Semaglutide works with your body’s natural systems to make weight loss sustainable and manageable.

Semaglutide is injected subcutaneously once weekly on the same day each week. Dosing starts at 0.25mg weekly for 4 weeks, then increases gradually to maintenance doses of 1.7-2.4mg weekly. Within 2-3 weeks, you’ll notice dramatically reduced appetite, elimination of constant hunger, and natural calorie reduction. Over 6-16 months, expect 12-15% total body weight loss – that’s 24-30 pounds for someone weighing 200 pounds.

Significant Weight Loss Results

Clinical trials show 12-15% average body weight reduction over 68 weeks at the 2.4mg dose – this is exceptional for pharmaceutical weight loss. Participants lost average of 33-35 pounds in clinical studies. Recent research shows even higher doses (7.2mg) produce 17-20% weight loss, approaching Tirzepatide’s results. The weight loss is sustained long-term with continued use.

Powerful Appetite Suppression

The most noticeable effect within days – Semaglutide dramatically reduces hunger signals and food cravings. The constant thoughts about food disappear. Many users report feeling satisfied with 40-50% less food than before. The appetite suppression makes dieting feel effortless rather than a constant battle against hunger.

Eliminates “Food Noise”

Users consistently report the obsessive mental chatter about food goes silent. The constant planning of next meal, the inability to focus due to hunger, the emotional eating triggers – they all significantly diminish. This psychological freedom is as valuable as physical weight loss.

Delayed Gastric Emptying

Semaglutide slows stomach emptying significantly, meaning food stays in your stomach longer. This creates prolonged satiety – feeling full for 5-8 hours after eating. The extended fullness makes intermittent fasting and calorie restriction sustainable without suffering.

Proven Long-Term Safety

With over 15 years of clinical use for diabetes and extensive weight loss studies, Semaglutide has established safety profile. The long-term data provides confidence that few weight loss medications can match. It’s been used by millions worldwide.

Improves Metabolic Health

Beyond weight loss, Semaglutide dramatically improves insulin sensitivity, lowers blood sugar, reduces A1C in diabetics by 1.5-2%, and improves overall metabolic function. Non-diabetic users see improved glucose control and reduced diabetes risk. The metabolic benefits persist even after weight loss.

Cardiovascular Benefits

Studies show reduced cardiovascular events, improved blood pressure, reduced triglycerides, improved cholesterol profiles. The SELECT trial demonstrated 20% reduction in major cardiovascular events (heart attack, stroke, CV death) in people with existing cardiovascular disease using Semaglutide.

Preserves Muscle Mass

When combined with resistance training and adequate protein, Semaglutide users maintain lean body mass better than crash dieters. The weight lost is predominantly fat tissue, creating improved body composition rather than just scale weight reduction.

This product isn’t intended to diagnose, treat, cure, or prevent any disease. Semaglutide is a prescription medication and should only be used under proper medical supervision for legitimate medical purposes.

Dosing Schedule (Standard Protocol):

Weeks 1-4: 0.25mg once weekly (starter dose)
Weeks 5-8: 0.5mg once weekly
Weeks 9-12: 1.0mg once weekly
Weeks 13-16: 1.7mg once weekly
Week 17+: 2.4mg once weekly (maximum standard dose)

When to Increase Dose:

Only increase every 4 weeks minimum - never increase more frequently. The gradual escalation minimizes gastrointestinal side effects. Many users find optimal results at 1.0-1.7mg weekly without needing maximum 2.4mg dose.

Advanced Dosing (Recent Research):

Studies show higher doses up to 7.2mg weekly produce additional weight loss (17-20% average) but require medical supervision and very gradual escalation beyond 2.4mg.

When to Inject:

Once weekly on the same day each week - set consistent schedule (e.g., every Monday morning). Can inject at any time of day, with or without food. Rotate injection sites (abdomen, thigh, upper arm).

Injection Method:

Subcutaneous injection into fatty tissue (abdomen preferred) using insulin needle. Inject slowly. Rotate sites each week to prevent lipohypertrophy.

Reconstitution:

If using lyophilized powder: Mix 5mg powder with 2ml bacteriostatic water. This creates 2.5mg/ml concentration. For 0.5mg dose = 0.2ml (20 units). For 1mg dose = 0.4ml (40 units). For 2.4mg dose = 0.96ml (96 units). Gently swirl until dissolved (do not shake).

Maintenance Strategy:

Once goal weight is reached, many users reduce to lowest effective maintenance dose (often 0.5-1.0mg weekly) to maintain weight loss without continuing escalation. Some users require continued 2.4mg for maintenance.

Most Common (Gastrointestinal):

Nausea (especially first 2-4 weeks or after dose increases)
Diarrhea or constipation
Stomach discomfort or abdominal pain
Vomiting (usually mild, temporary)
Indigestion or acid reflux
Reduced appetite (desired effect but can be very intense)

Less Common:

Fatigue or low energy (especially initially)
Headaches
Dizziness
Injection site reactions
Hair thinning (temporary, from rapid weight loss)

Serious Side Effects (Rare):

Pancreatitis (severe abdominal pain - discontinue immediately)
Gallbladder problems (gallstones from rapid weight loss)
Hypoglycemia (if combined with insulin or sulfonylureas)
Kidney problems (usually from dehydration)
Thyroid C-cell tumors (in animal studies, not confirmed in humans)

How to Manage:

Nausea: Take with small meal, avoid fatty/greasy foods, eat smaller portions, stay hydrated, consider anti-nausea medication. Significantly improves after 2-4 weeks. GI issues: Increase fiber, stay hydrated, eat slowly, smaller meals. Fatigue: Ensure adequate calories and protein despite reduced appetite. Dehydration risk: Drink minimum 8-10 glasses water daily. Get blood work checking kidney function if severe GI symptoms persist.

Active Ingredient: Semaglutide - GLP-1 receptor agonist peptide
Dosage Strength: 5 milligrams per vial
Quantity: Single vial (requires reconstitution if powder form)
Form: Lyophilized powder requiring reconstitution OR pre-mixed solution for injection

Intended Use:
Primary medical use: Type 2 diabetes management (Ozempic), chronic weight management in obesity (Wegovy), reducing cardiovascular risk.
Primary user applications: Fat loss, weight management, appetite control, metabolic health improvement, body recomposition.

Classification: Glucagon-like peptide-1 (GLP-1) receptor agonist

Mechanism of Action: Semaglutide is a 31-amino acid synthetic peptide analog of human GLP-1 with 94% sequence homology. It activates GLP-1 receptors with high potency. GLP-1 activation causes: increased glucose-dependent insulin secretion from pancreatic beta cells, decreased glucagon secretion (reduces glucose production), delayed gastric emptying creating prolonged satiety, reduced appetite through hypothalamic and brainstem pathways, increased satiety signaling reducing caloric intake. Unlike natural GLP-1 (half-life <2 minutes), Semaglutide's modifications provide ~7-day half-life allowing weekly dosing. The sustained GLP-1 receptor activation produces consistent appetite suppression and metabolic benefits.

Molecular Weight: Approximately 4113 g/mol (31 amino acids)
Half-Life: Approximately 7 days (165-184 hours, allows once-weekly dosing)
Time to Peak Plasma: 1-3 days post-injection
Bioavailability: 89% subcutaneous bioavailability

Effects on Metabolism:

Reduces fasting and postprandial glucose significantly
Increases insulin sensitivity
Reduces A1C by 1.5-2.0% in diabetics
Reduces appetite hormones (ghrelin)
Increases satiety hormones
Slows gastric emptying

Hepatotoxicity: None - not hepatotoxic
Renal Effects: Generally safe; ensure adequate hydration
Cardiovascular Effects: Positive - 20% reduction in major CV events

Administration: Subcutaneous injection into abdomen (preferred), thigh, or upper arm using insulin needle. Inject once weekly on consistent schedule. Rotate injection sites.

Storage: Must be refrigerated at 36-46°F (2-8°C) before and after reconstitution. Do not freeze. Protect from light. Use within 56 days of first use. Can be kept at room temperature up to 56 days if needed.

Also Known As: Semaglutide, Ozempic (diabetes brand), Wegovy (weight loss brand), Rybelsus (oral formulation)